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Abstract
The proteasome inhibitor MG132 had been shown to prevent galactose induction of the S. cerevisiae GAL1 gene,
demonstrating that ubiquitin proteasome-dependent degradation of transcription factors plays an important role in the
regulation of gene expression. The deletion of the gene encoding the F-box protein Mdm30 had been reported to stabilize
the transcriptional activator Gal4 under inducing conditions and to lead to defects in galactose utilization, suggesting that
recycling of Gal4 is required for its function. Subsequently, however, it was argued that Gal4 remains stably bound to the
enhancer under inducing conditions, suggesting that proteolytic turnover of Gal4 might not be required for its function. We
have performed an alanine-scanning mutagenesis of ubiquitin and isolated a galactose utilization-defective ubiquitin
mutant. We have used it for an unbiased suppressor screen and identified the inhibitor Gal80 as a suppressor of the
transcriptional defects of the ubiquitin mutant, indicating that the protein degradation of the inhibitor Gal80, and not of the
activator Gal4, is required for galactose induction of the GAL genes. We also show that in the absence of Gal80, Mdm30 is
not required for Gal4 function, strongly supporting this hypothesis. Furthermore, we have found that Mediator controls the
galactose-induced protein degradation of Gal80, which places Mediator genetically upstream of the activator Gal4. Mediator
had originally been isolated by its ability to respond to transcriptional activators, and here we have discovered a leading role
for Mediator in the process of transcription. The protein kinase Snf1 senses the inducing conditions and transduces the
signal to Mediator, which initiates the degradation of the inhibitor Gal80 with the help of the E3 ubiquitin ligase SCF
Mdm30.
The ability of Mediator to control the protein degradation of transcriptional inhibitors indicates that Mediator is actually able
to direct its own recruitment to gene promoters.
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Introduction
Cells regulate the expression of their genes according to
requirement [1]. Activators recruit chromatin-remodeling or
chromatin-modifying complexes that change the structure of
chromatin to promote transcription [2,3], while repressors recruit
chromatin-modifying complexes that change the structure of
chromatin to prevent transcription [4,5]. Repressors also bind
directly to activators and prevent the recruitment of the
transcription machinery [6]. According to the reverse recruitment
hypothesis [7], the transcription factors do not move to the highly
transcribed genes, but the highly transcribed genes move to the
gene expression machines (GEMs), which are protein complexes
with fixed locations in the nuclear periphery. GEMs, which host
all transcription factors that are required for gene expression from
RNA Polymerase to RNA capping, splicing, poly-adenylation, and
export factors [8], are associated with the nuclear pores, and the
mature mRNAs, once produced at the GEM, are immediately
exported out of the nucleus to be translated at the ribosomes of the
rough endoplasmic reticulum [7].
The Saccharomyces cerevisiae GAL genes are a paradigm for
transcriptional regulation in eukaryotes [9]. In cells grown with
glucose, Gal80 binds to Gal4 and blocks its activation function
[10], while Mig1 binds to an upstream silencer and recruits the
general repressor Tup1 to prevent gene expression [11]. Upon the
switch to galactose media, Snf1 phosphorylates Mig1, causing its
translocation from the nucleus to the cytoplasm [12], while Gal80
dissociates from Gal4 [13] and is sequestered in the cytoplasm by
Gal3 [14], leaving Gal4 free to activate the GAL genes, which are
required for galactose utilization [7].
Proteolytic stability of transcription factors offers an intriguing
possibility for the eukaryotic cell to control gene expression [15].
Ubiquitin proteasome-dependent degradation (UPD) of activators
and repressors plays an important role in gene regulation [16], and
treatment of S. cerevisiae cells with the proteasome inhibitor MG132
abolished galactose induction of the GAL1 gene [17]. Ubiquitin is a
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ligases to proteins to be targeted for degradation by the 26S
proteasome [18]. F-box proteins confer substrate specificity to SCF
(Skip1-Cullin-F-box protein) E3 ubiquitin ligases [19]. When cells
are grown with galactose, an SCF E3 ubiquitin ligase containing
the F-box protein Mdm30, SCF
Mdm30, ubiquitinates Gal4 [20].
The deletion of MDM30 stabilizes Gal4 under inducing conditions
and leads to defects in galactose utilization, suggesting that
recycling of Gal4 is required for its transcriptional activator
function [20]. Subsequently, however, it was argued that Gal4
remains stably bound to the enhancer under inducing conditions,
suggesting that proteolytic turnover of Gal4 might not be required
for its function [21–23]. Previously, it had been shown that mono-
ubiquitination protected Gal4 from the promoter-stripping activity
of proteasomal ATPases [24–26], suggesting a role for ubiquitin in
transcriptional activation other than protein degradation. Recent-
ly, it has been reported that the proteolytic stability of Mediator
subunits is inversely correlated with their ability to activate
transcription when fused to a DNA-binding domain [27].
Mediator is a complex of more than 20 proteins that is
conserved from yeast to man [28]. It was discovered by its ability
to respond to transcriptional activators in vivo and in vitro [29].
Genome-wide gene expression studies with temperature-sensitive
alleles have shown that Mediator is required for the transcription
of nearly all RNA Polymerase II–dependent genes in yeast [30].
Mediator interacts directly with activators, General Transcription
Factors, and RNA Polymerase II [31]. In higher eukaryotes,
Mediator facilitates a DNA loop between enhancer and basal
promoter via its interaction with cohesin [32]. In addition,
Mediator affects steps that are downstream of the recruitment of
RNA Polymerase II to the core promoter, as Med26-containing
metazoan Mediator switches RNA Polymerase into the productive
transcription elongation mode by an interaction of Med26 with
TBP (TATA-binding protein) and the CTD (C-terminal domain
of RNA Polymerase II) kinase P-TEFb [33]. Mediator also
modifies chromatin via its own CDK8 subunit, which phosphor-
ylates histone H3S10, and by its interaction with histone acetyl-
and methyltransferases [34,35]. Metazoan Mediator plays impor-
tant roles in neurogenesis, cancer formation, and stem cell
proliferation [31]. All of these reported functions of Mediator
are genetically downstream of transcriptional activators. Here, we
have found that Mediator additionally is able to act upstream of
the transcriptional activator Gal4 by controlling the ubiquitin-
mediated protein degradation of the inhibitor Gal80. In the
absence of Gal80, Gal4 is free to recruit Mediator to the promoter
of the GAL genes. Therefore, Mediator actually orchestrates its
own recruitment to the GAL promoters upon galactose induction.
Results
Gal80 Is Stable in a gal
2 Ubiquitin Mutant Strain
The role of ubiquitin proteasome-dependent protein degrada-
tion in the transcriptional regulation of the GAL genes has been
controversial [19–22]. We performed an alanine-scanning muta-
genesis of ubiquitin in order to isolate galactose-utilization
defective (gal
2) mutant strains and use these for unbiased multi-
copy suppressor screens. However, no ubiquitin single point
mutant displaying the gal
2 phenotype was isolated (Figure S1,
even lanes; Figure S2). The addition of an N-terminal tag can
sometimes enhance the phenotype of point mutants, and so we
fused a stretch of 10 N-terminal histidines to all ubiquitin mutant
proteins. S. cerevisiae cells expressing H10UbF4A, H10UbK6A,
H10UbI13A, H10UbR42A, H10UbF45A, H10UbD58A, and
H10UbT66A in the place of endogenous ubiquitin displayed
growth defects on galactose plates containing the respiration
inhibitor Antimycin A (AA; Figure S1, lanes 5, 11, 23, 85, 87, 105,
119; Figure S2). The presence of the respiration inhibitor AA
requires the cells to metabolize more galactose molecules in order
to form colonies, which serves to translate defects in the
transcriptional activation of the GAL genes into stronger growth
defects on galactose plates. The H10UbD58A mutant strain was
also unable to grow on galactose plates in the absence of AA
(Figure 1A, line 5), and it was transformed with a multi-copy
library of S. cerevisiae genomic DNA fragments [36]. Gal3 was
isolated by its ability to confer growth to the H10UbD58A mutant
strain on galactose plates upon over-expression (Figure 1A, line 6).
The over-expression of Gal3 also dosage-compensated the gal
2
phenotype of the other H10Ub mutant strains (Figure S3, compare
odd and even lanes; the H10UbF4A mutant strain was barely viable
and was excluded from further studies). Gal3 sequesters Gal80 in
the cytoplasm upon galactose induction [10], and our finding that
the over-expression of Gal3 suppressed the gal
2 phenotype of the
H10Ub mutant strains indicated that ubiquitin-mediated protein
degradation of Gal80 could be required for galactose induction of
the GAL genes and that the gal
2 phenotype of these H10Ub mutant
strains might have been caused by excess Gal80. Consistently, the
additional gene deletion of GAL80 suppressed the gal
2 phenotype
of the H10UbD58A mutant (Figure 1A, line 7) and of the other
H10Ub mutant strains (Figure S4, compare odd and even lanes).
Reverse transcription coupled with real-time PCR quantification
revealed that galactose induction of GAL1 mRNA relative to ACT1
mRNA was abolished in the H10UbD58A strain and that the over-
expression of Gal3 and the additional gene deletion of GAL80
(partially) restored galactose induction (Figure 1B). We performed
chase assays with the protein biosynthesis inhibitor cycloheximide
and found that HA-Gal80 was indeed degraded in galactose-
induced H10Ub cells (Figure 1C, lanes 5 to 8; Figure 1D, white
bars). Importantly, HA-Gal80 had become stable in galactose-
induced H10UbD58A mutant cells (Figure 1C, lanes 13 to 16;
Figure 1D, black bars) as well as in the other gal
2 H10Ub mutants
strains (Figure S5), suggesting that the galactose-stimulated protein
degradation of Gal80 is necessary for transcriptional activation of
Author Summary
The expression levels of proteins are tightly regulated, not
only via their production but also via their degradation.
Genes are transcribed only if their encoded proteins are
required by the environmental or developmental condi-
tions of a cell, and once a certain protein is no longer
needed, it is rapidly degraded by the ubiquitin proteasome
system (UPS). Transcriptional activators appeared to
contradict this simple economic principle, as it had been
claimed that they had to be degraded in order to function.
The claim was based upon a correlation: if the degradation
of an activator was prevented by drugs or mutations in the
UPS, the activator became stable but also nonfunctional.
We have now shown that it is not the activator itself but its
inhibitor that is the functionally relevant target of the UPS.
Furthermore, we have found that the degradation of the
inhibitor is controlled by a protein complex called
Mediator. The activator is known to recruit Mediator to
gene promoters, where Mediator assists RNA polymerase
in initiating transcription. Mediator was always considered
to be completely under the control of the activator;
however, we observe that by regulating the degradation
of the inhibitor, Mediator is also able to control the
activator and thereby to orchestrate its own recruitment to
gene promoters.
Mediator Acts Upstream of Activator
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GAL80 suppressed the gal
2 phenotype of the H10Ub mutant strains
provides genetic evidence that the failure to degrade Gal80 had
been the cause (and not the consequence) of the gal
2 phenotype of
the H10Ub mutant strains.
Galactose Induction Requires Gal80 Degradation
E3 ubiquitin ligases add ubiquitin to proteins that are targeted
for degradation by the 26S proteasome [18], and Skp1 is an
essential component of all SCF E3 ubiquitin ligases [19].
Previously, we had found that the Skp1 derivative Nub-HA-
Skp1V90A,E129A (Skp1dM) causes the gal
2 phenotype when
expressed in place of endogenous Skp1 [37]. We had isolated a2a s
a multi-copy suppressor and shown that galactose-induced protein
degradation of the repressor Mig2, which—like a2 [38]—uses the
co-repressor Tup1, was abolished in the skp1dM strain [37]. The
most likely explanation was that over-expression of a2 had titrated
Tup1 away from GAL1 promoter-bound Mig2, which—like Mig1
[39]—activated transcription in the absence of Tup1. The
additional gene deletion of MIG2, however, had only partially
suppressed the gal
2 phenotype of the skp1dM strain [37],
suggesting that Skp1 mediated the galactose-induced protein
degradation of additional transcription factors. Therefore, we
wanted to see if Gal80 was a functionally relevant target of SCF E3
ubiquitin ligases. HA-Gal80 protein was degraded in galactose-
induced SKP1 wild-type cells (Figure 2A, lanes 5 to 8; Figure 2B,
white bars), while it was stable in galactose-induced skp1dM cells
(Figure 2A, lanes 13 to 16; Figure 2B, black bars), indicating that
wild-type Skp1 was required for the galactose-induced protein
degradation of Gal80. We transformed the skp1dM mutant strain
with multi-copy plasmids expressing Sgt1 (which is required for
Skp1-dependent cyclin degradation [40]), a2, Ubp3 (which
dosage-compensates the gal
2 phenotype of cells expressing the
proteolytically instable Tbp1E186D [41]), and Gal3. The over-
expression of Sgt1 suppressed the temperature sensitivity of the
skp1dM strain (Figure 2C, line 3). The over-expression of Gal3 and
Figure 1. Gal80 is stable in galactose-induced H10UbD58A cells. (A) SUB288GAL3DWL cells expressing the indicated ubiquitin derivative in
place of endogenous ubiquitin were 10-fold serially diluted, titrated onto glucose and onto galactose plates, and incubated at 28uC for 6 d. Cells in
lines 3 and 6 over-expressed Gal3 from the ACT1 promoter, while cells in lines 4 and 7 lacked GAL80. (B) SUB288GAL3DL cells expressing H10Ub and
H10UbD58A in place of endogenous ubiquitin as indicated were grown in glucose liquid media to OD600 nm=1 (Glu) and induced with galactose
liquid media for 6 h (Gal). Cells over-expressed Gal3 from the ACT1 promoter or lacked GAL80 as indicated. Total RNA was isolated and the amount of
GAL1 mRNA relative to ACT1 mRNA was determined with reverse transcription-coupled real-time PCR. The value determined for cells expressing
H10Ub grown with glucose was set as 1, and the error bars indicate the standard deviations between three replicates. (C) SUB288GAL3DL cells
expressing H10Ub (lanes 1 to 8) or H10UbD58A (lanes 9 to 16) in place of endogenous ubiquitin were transformed with the single-copy vector RS316
expressing HA-Gal80 under the control of the ACT1 promoter. Cells were grown in glucose liquid media to OD600 nm=1 and induced with galactose
liquid media for 1 h. Cycloheximide was added at time=0 and the amount of Gal80 protein remaining in the cells after the indicated number of
hours was determined by Western blot with the help of an anti-hemagglutinin (HA) antibody (upper panels). The membranes were stripped and
reprobed with an anti-carboxypeptidase Y (CPY) antibody (middle panels), followed by a second stripping and staining with Coomassie Blue as
loading controls (lower panels). (D) The ratio of the amount of HA-Gal80 protein to CPY protein in H10-Ub cells (white bars) and H10-UbD58A cells
(black bars) for each time point in part C was determined with Image J. The ratio of the band intensities before the addition of cycloheximide
(time=0) was set as 1, and the error bars indicate the deviations between duplicates.
doi:10.1371/journal.pbio.1001290.g001
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2 phenotype, but not the temperature
sensitivity, of the skp1dM mutant strain (Figure 2C, lines 4 and 6),
while the over-expression of Ubp3 had no effect (Figure 2C, line
5). Real-time PCR quantification revealed that galactose induction
of GAL1 mRNA relative to ACT1 mRNA was abolished in the
skp1dM mutant strain (Figure 2D) and that it was restored to some
550-fold in the presence of excess Gal3 and almost fully in the
absence of Gal80 (Figure 2D), providing genetic evidence that
galactose-stable Gal80 had been the main cause for the gal
2
phenotype of the skp1dM strain.
SCF
Mdm30 Targets Gal80
F-box proteins provide the substrate specificity to SCF E3
ubiquitin ligases [19], and the deletion of the gene encoding the F-
box protein Mdm30 causes a gal
2 phenotype [20]. Cycloheximide
chase assays demonstrated that HA-Gal80 was degraded in
galactose-induced BY4741DW wild-type cells (Figure 3A, lines 5
to 8; Figure 3B, white bars), while it was stable in galactose-
induced DMDM30 cells (Figure 3A, lines 13 to 16; Figure 3B,
black bars), suggesting that SCF
Mdm30 targets Gal80 for galactose-
induced protein degradation. Importantly, and consistent with a
recent report [42], the additional gene deletion of GAL80
suppressed the gal
2 phenotype of the DMDM30 strain
(Figure 3C, line 4). Gal80 was still degraded in galactose-induced
DGAL11 cells (Figure 3A, lanes 21 to 24; Figure 3B, grey bars) and
the additional gene deletion of GAL80 did not suppress the gal
2
phenotype of cells lacking Gal11 (Figure 3C, line 6), confirming
that the suppression of the gal
2 phenotype of the DMDM30 strain
by the additional gene deletion of GAL80 was gene-specific and
that the F-box protein Mdm30 acts genetically upstream of the
repressor Gal80, while the Mediator component Gal11 (Med15;
which is a target of Gal4 [43]) acts genetically downstream of the
repressor Gal80. Real-time PCR quantification of GAL1 mRNA
relative to ACT1 mRNA confirmed that the additional gene
deletion of GAL80 fully suppressed the transcriptional defect of the
DMDM30 strain (Figure 3D), suggesting that Mdm30 targets
Figure 2. Galactose induction requires SCF-mediated Gal80 degradation. (A) JD52 cells whose chromosomal SKP1 gene had been replaced
by HIS3 and that expressed Nub-Skp1 (SKP1wt) or Nub-Skp1V90A,E129A (skp1dM) under the control of its own promoter from the single-copy vector
PSCNX were transformed with the single-copy vector RS316 expressing HA-tagged Gal80 under the control of the ACT1 promoter. Cells were grown in
glucose liquid media to OD600 nm=1 and induced with galactose liquid media for 1 h. Cycloheximide was added at time=0 and the amount of Gal80
protein remaining in the cells after the indicated number of minutes was determined by Western blot with the help of an anti-HA antibody (upper
panels). The membranes were stripped and stained with Coomassie Blue as loading controls (lower panels). (B) The ratio of the amount of HA-Gal80
protein to total protein (Coomassie) in SKP1wt cells (white bars) and skp1dM cells (black bars) for each time point in part A was determined with
Image J. The ratio of the band intensities before the addition of cycloheximide (time=0) was set as 1 and the error bars indicate the deviations
between duplicates. (C) JD52 cells expressing Nub-Skp1wt (line 1) and Nub-Skp1dM (lines 2 to 7) in place of endogenous Skp1 were 10-fold serially
diluted, titrated onto the indicated plates, and incubated for 3 d on glucose plates and for 6 d on galactose plates containing 0.1 mg/l of the
respiration inhibitor Antimycin A (AA). Cells over-expressed the indicated proteins from the multi-copy vector YEplac112 under the control of their
own respective promoters. Cells in line 7 expressed Skp1 from the single-copy vector YCplac22 under the control of its own promoter. (D) JD52 cells
of the indicated genotype were grown in glucose liquid media to OD600 nm=1 and induced with galactose liquid media for 8 h. Cells over-expressed
Gal3 from RS314 under the control of the ACT1 promoter or lacked GAL80 as indicated. Total RNA was isolated and GAL1 mRNA was determined
relative to ACT1 mRNA by quantitative real-time PCR. The value determined for SKP1wt cells grown with glucose liquid media was set as 1 and the
error bars indicate the standard deviations between three replicates.
doi:10.1371/journal.pbio.1001290.g002
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PLoS Biology | www.plosbiology.org 4 March 2012 | Volume 10 | Issue 3 | e1001290Figure 3. Gal80 is the main target of Mdm30. (A) HA-tagged Gal80 was expressed in BY4741DW cells of the indicated genotype. Cells were
grown in glucose liquid media to OD600 nm=1 and induced with galactose liquid media for 1 h. Cycloheximide was added at time=0 and the amount
of Gal80 protein remaining in the cells after the indicated number of hours was determined by Western blot with the help of an anti-HA antibody
(upper panels). The membranes were stripped and stained with Coomassie Blue as loading controls (lower panels). (B) The ratio of the amount of HA-
Gal80 protein to total protein (Coomassie) in BY4741DW cells (white bars), BY4741DWDMDM30 cells (black bars), and BY4741DWDGAL11 cells (grey
bars) for each time point in part A was determined with Image J. The ratio of the band intensities before the addition of cycloheximide (time=0) was
set as 1 and the error bars indicate the deviations between duplicates. (C) BY4741DW cells of the indicated genotype were 10-fold serially diluted,
titrated onto the indicated plates, and incubated for 3 d on the glucose plate and for 6 d on the galactose plate. (D) BY4741DW cells of the indicated
genotype were grown in glucose liquid media to OD600 nm=1 (Glu) and induced with galactose liquid media for 8 h (Gal). Total RNA was isolated and
GAL1 mRNA was determined relative to ACT1 mRNA by quantitative real-time PCR. The value determined for BY4741DW wild-type cells grown with
glucose liquid media was set as 1 and the error bars indicate the standard deviations between three replicates. (E) HA3-tagged Mdm30 and GST or
GST-Gal80 were co-expressed in BY4741DW cells under the control of the ACT1 promoter from the multi-copy vectors RS423 and RS424, respectively.
Cells were grown with glucose liquid media to OD600 nm=1 (odd lanes) and induced in galactose liquid media for 1 h (even lanes). GST and GST-
Gal80 were pulled down from cell extracts with the help of glutathione beads, and Inputs and GST Pulldowns were analyzed by Western blots with
the help of an anti-HA antibody (upper panel) and an anti-GST antibody (middle panel). The membrane was stripped and stained with Coomassie in
order to compare the amount of protein loaded for Input and GST Pulldown (bottom panel). (F) Histidine-tagged ubiquitinated proteins were
precipitated with Ni-beads from extracts of glucose-grown (Glu) and galactose-induced (Gal) SUB288DWL (lanes 1, 2, 5, 6, 7) and SUB288DWLDMDM30
(lanes 3, 4, 8, 9) cells expressing HA-Gal80 and ubiquitin (lane 5) or histidine-tagged ubiquitin (lanes 1 to 4 and 6 to 9) in place of endogenous
ubiquitin. Inputs (lanes 1 to 4) and precipitates (lanes 5 to 9) were analyzed by Western blot with the help of an anti-HA antibody. The ubiquitinated
bands appear as doublets, indicating that more than one lysine in Gal80 is subject to ubiquitination.
doi:10.1371/journal.pbio.1001290.g003
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tently, GST-Gal80, but not GST, pulled down HA-tagged
Mdm30 and Skp1 from yeast extracts (Figure 3E, lanes 8 and 9;
Figure S6). Coomassie staining demonstrated that Gal80 and
Mdm30 interacted at approximately equal amounts (Figure 3E,
lanes 8 and 9). However, Gal80 interacted with Mdm30 (and
Skp1) not only in galactose-induced but also in glucose-grown cells
(Figure 3D, compare lanes 8 and 9; Figure S6), possibly reflecting
the (slower) protein degradation of Gal80 in cells grown with
glucose (Figure 3A, lane 4; Figure 3B, white bars). The half-life of
Gal80 was calculated to be approximately 3 h in glucose-grown
BY4741DW cells and approximately 1 h in galactose-induced
BY4741DW cells. Gal80 had been completely stable in glucose-
grown H10Ub cells (Figure 1, lines 1 to 4), indicating that the N-
terminal tail of 10 histidines might have interfered with the slow
protein degradation of Gal80 in glucose-grown cells. In agreement
with the hypothesis that Gal80 is not just degraded in galactose-
induced but also in glucose-grown cells (albeit with slower kinetics),
Gal80 was poly-ubiquitinated in cells grown with glucose and in
cells induced with galactose (Figure 3F, lanes 6 and 7). The
amount of poly-ubiquitinated species of Gal80 was only slightly
higher in galactose-induced cells as compared to in glucose-grown
cells, suggesting that the generation of the poly-ubiquitinated
species of Gal80 is rate-limiting, and once generated, poly-
ubiquitinated Gal80 is immediately degraded. The ubiquitinated
forms of HA-Gal80 are not visible in the input lanes, indicating
that only a very small fraction of the Gal80 inside the cell is
ubiquitinated at any point in time. The figure further shows that
Gal80 was poly-ubiquitinated in wild-type cells as well as in cells
lacking Mdm30 (Figure 3F, compare lanes 7 and 9), indicating
that Mdm30 is not the only F-box protein targeting Gal80. In
order to identify additional SCF E3 ubiquitin ligases targeting
Gal80, we tested galactose utilization defective F-box protein gene
deletion mutant strains [37] and found that Gal80 was also stable
in galactose-induced cells lacking the F-box proteins Das1 and
Ufo1 (Figure S7A,B). Importantly, the gal
2 phenotype of cells
lacking Das1 and Ufo1 was suppressed by the additional gene
deletion of GAL80 (Figure S7C) and GST-Gal80, but not GST,
pulled down Das1, and Ufo1 from yeast extracts (Figure S7D,E),
indicating that targeting of Gal80 by at least these three F-box
proteins is required for the efficient galactose-induced protein
degradation of Gal80. Gal80 interacted with all three F-box
proteins in cells grown with glucose and in cells grown with
galactose. Consistently, the deletion of MDM30, DAS1, and UFO1
stabilized Gal80 also in glucose-grown cells (Figures 3B and S7B).
The signal observed for the pulldown of the F-box proteins with
GST-Gal80 was higher in glucose-grown cells than in galactose-
induced cells (compare lanes 8 and 9 in Figures 3E and S7D,E). A
possible explanation is that in galactose-induced cells, more than
in glucose-grown cells, the protein-protein interaction between the
F-box proteins and Gal80 resulted in the protein degradation of
Gal80, which means that the amount of the F-box protein pulled
by GST-Gal80 does not necessarily reflect the strength of the
protein-protein interaction. The over-expression of Mdm30 and
Ufo1 suppressed the gal
2 phenotype of cells lacking Das1 (Figure
S7F, lanes 3 and 4), indicating that galactose induction requires a
critical threshold of Gal80-targeting SCF E3 ubiquitin ligases.
Stable Derivatives of Gal80 Inhibit Galactose Induction
SCF E3 ubiquitin ligases are enzymes that not only target Gal80
for ubiquitin proteasome-mediated protein degradation but also
other proteins like Gal4 [20] and Mig2 [37]. It could be argued
that defects in the protein degradation of some protein other than
Gal80 had caused the gal
2 phenotype of the H10UbD58A, skp1dM,
and DMDM30 mutant strains. We have shown that the additional
gene deletion of GAL80 suppressed the transcriptional defects of all
of these mutants, indicating that Gal80 is the only functionally
relevant target, but in order to gain independent evidence that the
galactose-induced protein degradation of Gal80 is required for the
galactose induction of the GAL genes, we sought to generate a
galactose-stable Gal80 derivative that would interfere with
transcriptional activation of the GAL genes. Some degraded
proteins contain an N-terminal degron, and we performed a series
of small N-terminal deletions of Gal80 and tested them for causing
defects in galactose utilization. The over-expression of wild-type
HA-Gal80 reduced growth on a galactose plate in the presence of
the respiration inhibitor Antimycin A (Figure 4A, line 2). The
successive deletion of two amino acids increased the growth
inhibition, with the deletion derivative lacking the 12 N-terminal
amino acids of Gal80 showing the biggest growth inhibition
(Figure 4A, line 6). N-terminal deletions of more than 12 amino
acids resulted in less inhibition, with the Gal80 deletion derivative
lacking the N-terminal 20 amino acids (which removes the first
four residues of the Rossmann-fold [44]) having lost the ability to
inhibit growth on the galactose plate (Figure 4A, line 10). Real-
time PCR quantification of GAL1 mRNA relative to ACT1 mRNA
showed that the over-expression of the HA-Gal80 derivative
lacking the N-terminal 12 amino acids reduced galactose induction
of the GAL1 gene 5- to 3-fold more than the over-expression of
wild-type HA-Gal80 (Figure 4B). Cycloheximide chase assays
demonstrated that the HA-Gal80 deletion derivative lacking the
N-terminal 12 amino acids was indeed stable in galactose-grown
cells (Figure 4C, lanes 19 to 24; Figure 4D, black bars), confirming
our hypothesis that galactose induction of the GAL1 gene requires
protein degradation of the repressor Gal80.
Mediator Interacts with SCF E3 Ubiquitin Ligases
The essential Mediator subunit Srb7 (Med21) plays a pivotal
role in the regulation of transcription [45,46]. In order to identify
human proteins interacting with the human Mediator component
hSrb7, we fused it to the C-terminal half of ubiquitin that was
extended by the RUra3 reporter (Cub-RUra3) and performed a
Split-Ubiquitin screen [47,48] with an expression library of human
cDNAs fused to the N-terminal half of ubiquitin (Nub; Figure
S8A). The Nub fusion of the human SCF E3 ubiquitin ligase
component hSkp1 was isolated by its ability to confer FOA
resistance to S. cerevisiae cells expressing hSrb7-Cub-RUra3 (Figure
S8B), indicating that both proteins interacted inside the yeast cells.
E. coli–expressed GST-hSrb7, but not GST, pulled down Nub-
HA-hSkp1 from yeast extract (Figure S8C, lane 6), and E. coli–
expressed GST-hSkp1, but not GST, pulled down E. coli–
expressed H6-HA-hSrb7 (Figure S8C, lane 3), demonstrating that
both proteins interacted directly with each other also in vitro. The
human Split-Ubiquitin system (Figure S8D; [49]) was used to
demonstrate that both proteins interacted with each other also in
vivo (Figure S8E). hSrb7 and hSkp1 are subunits of distinct protein
complexes, but the SCF component hSkp1 might play an
additional role as a component of Mediator, while the Mediator
component hSrb7 might moonlight as a component in an SCF
complex. In order to distinguish between these possibilities, we
performed co-immunoprecipitations with HeLa extracts and
found that hSkp1 pulled down other Mediator components like
hMed6 (Figure S9A, lane 3), while hMed6 pulled down other SCF
components like hCul1 (Figure S9A, lane 10), indicating that
hSrb7 and hSkp1 interacted with each other as components of
their own respective complexes. We knocked down hSrb7 and
hSkp1 in HeLa cells by RNA interference (Figure S9B), which
dramatically reduced the heat-shock induction of the human
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functionally relevant for transcription in human cells. Skp1 is a
component of the SCF E3 ubiquitin ligases, suggesting that protein
degradation could be an important aspect of how Srb7 regulates
transcription.
Mediator Controls Gal80 Degradation
The Split-Ubiquitin assay revealed that also the S. cerevisiae Srb7
and Skp1 proteins interacted with each other in vivo (Figure 5A,
line 2). Interestingly, Skp1dM was defective for the protein
interaction with Srb7 (Figure 5A, line 4). Our results showed that
the Mediator of transcription interacts with SCF E3 ubiquitin
ligases, and in order to see if Mediator plays a role in the galactose-
induced protein degradation of Gal80, we generated a gal
2 allele
of SRB7 by replacing endogenous Srb7 with a GST fusion to a C-
terminal fragment of Srb7 lacking the first 40 amino acid residues
(Figure 5B, line 2). The over-expression of Gal3 and the deletion of
GAL80 suppressed the gal
2 phenotype of the GST-Srb7D40 strain
(Figure 5B, compare lines 1 to 4), indicating that excess Gal80
could have caused the gal
2 phenotype. The over-expression of
Gal3 and the deletion of GAL80 did not suppress the gal
2
phenotype of cells lacking the Mediator subunit Gal11 (Figure 5B,
compare lines 5 to 7), demonstrating that the suppression had been
gene-specific and that the Mediator subunit Srb7 acts genetically
upstream of Gal80, while the Mediator subunit Gal11 acts
genetically downstream of Gal80. The over-expression of a2 and
the deletion of MIG2 did not suppress the gal
2 phenotype of the
GST-Srb7D40 strain (Figure 5B, compare lines 8 to 11), while the
over-expression of a2 and the deletion of MIG2 had suppressed
(partially) the gal
2 phenotype of the skp1dM strain (Figure 2C, line
4 and [37]), suggesting that Skp1 acts genetically upstream of both
Gal80 and Mig2, while Srb7 acts genetically upstream of Gal80
only. Cycloheximide chase assays demonstrated that Gal80 was
degraded in galactose-induced cells expressing wild-type Srb7
(Figure 5C, lanes 5 to 8; Figure 5D, white bars), but stable in
galactose-induced GST-Srb7D40 cells (Figure 5C, lanes 13 to 16;
Figure 5D, black bars), indicating that Mediator controls the
galactose-induced protein degradation of Gal80. Real-time PCR
quantification confirmed that galactose induction of GAL1 mRNA
relative to ACT1 mRNA was abolished in the GST-Srb7D40 strain
and that it was almost fully restored by the over-expression of Gal3
and the deletion of GAL80 (Figure 5E), suggesting that the failure
Figure 4. A galactose-stable Gal80 deletion derivative inhibits galactose induction of the GAL1 gene. (A) BY4742DW cells over-
expressing the indicated HA-Gal80 deletion derivatives from RS316 under the control of the ACT1 promoter were 10-fold serially diluted, titrated onto
the indicated plates, and incubated for 3 d (Glucose) and 6 d (Galactose+AA=1 mg/l Antimycin A), respectively. (B) Cells of part A, lines 1, 2 and 6,
were grown in glucose liquid media to OD600 nm=1 and induced with galactose liquid media for the indicated number of hours. Total RNA was
isolated and GAL1 mRNA was determined relative to ACT1 mRNA by quantitative real-time PCR. The value determined for BY4742DW cells containing
RS316 grown with glucose liquid media was set as 1 and the error bars indicate the standard deviations between three replicates. (C) BY4742DW cells
expressing HA-tagged wild-type Gal80 or Gal80DN12 from RS317 under the control of the ACT1 promoter were grown in glucose liquid media to
OD600 nm=1 and induced with galactose liquid media for 1 h. Cycloheximide was added at time=0 and the amount of HA-Gal80 and HA-Gal80DN12
proteins remaining in the cells after the indicated number of minutes was determined by Western blot with the help of an anti-HA antibody (upper
panels). The membranes were stripped and reprobed with an anti-CPY antibody (middle panels), followed by a second stripping and staining with
Coomassie Blue as loading controls (lower panels). (D) The ratio of the amount of HA-Gal80 protein to CPY protein (white bars) and of HA-Gal80DN12
protein to CPY protein (black bars) in BY4742DW cells for each time point in part C was determined with Image J. The ratio of the band intensities
before the addition of cycloheximide (time=0) was set as 1 and the error bars indicate the deviations between duplicates.
doi:10.1371/journal.pbio.1001290.g004
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induction had been the main cause for the failure to activate the
transcription of the GAL1 gene. GST-Srb7, but not GST, pulled
down Skp1 from yeast extract, while GST-Srb7D40 failed to do so
(Figure 5F, lanes 5 and 6), indicating that the protein-protein
interaction with Skp1 is mediated by the N-terminus of Srb7,
which is the most conserved part of the protein [46]. Our results
have shown that the degradation of Gal80 was abolished when
endogenous Skp1 was replaced by a mutant Skp1 derivative that
failed to interact with Srb7 and when endogenous Srb7 was
Figure 5. Mediator controls galactose-induced Gal80 degradation. (A) JD52 cells expressing Srb7 fused to Cub-RUra3 and Nub-HA fused to
the indicated derivatives of Skp1 were titrated onto the depicted plates and incubated for 3 d (Skp1dM=Skp1V90A,E129A). Protein-protein
interaction between Srb7 and Skp1 is indicated by lack of growth on the uracil-depleted plate and by growth on the FOA-containing plate. (B) JD52
cells whose chromosomal SRB7 gene had been replaced by HIS3 and that expressed wild-type Srb7 under the control of its own promoter from the
single-copy vector YCplac22 (22-SRB7; lines 1 and 8) or GST-Srb7 lacking the first 40 amino acids of Srb7 from the multi-copy vector YG1u under the
control of the ADH1 promoter (GST-Srb7D40; lines 2 to 4 and lines 9 to 11) and BY4741DW cells of the indicated genotype (lines 5 to 7) were 10-fold
serially diluted, titrated onto the depicted plates, and incubated for 3 d on the glucose plate and for 6 d on the galactose plate containing 0.1 mg/l
AA. Cells in lines 3 and 6 over-expressed Gal3 from RS315 under the control of the ACT1 promoter, cells in line 10 over-expressed a2 from RS315 under
the control of the ACT1 promoter, cells in lines 4 and 7 lacked GAL80, and cells in line 11 lacked MIG2. (C) JD52 cells whose chromosomal SRB7 gene
had been replaced by HIS3 and that expressed wild-type Srb7 under the control of its own promoter from the single-copy vector YCplac22 (22-SRB7)
or GST-Srb7 lacking the first 40 amino acids of Srb7 from the multi-copy vector YG1u under the control of the ADH1 promoter (GST-Srb7D40) were
transformed with the single-copy vector RS316 expressing HA-tagged Gal80 under the control of the ACT1 promoter. Cells were grown in glucose
liquid media to OD600 nm=1 and induced with galactose liquid media for 1 h. Cycloheximide was added at time=0 and the amount of Gal80 protein
remaining in the cells after the indicated number of minutes was determined by Western blot with the help of an anti-HA antibody (upper panels).
The membranes were stripped and stained with Coomassie Blue as loading controls (lower panels). (D) The ratio of the amount of HA-Gal80 protein
to total protein (Coomassie) in 22-SRB7 cells and GST-Srb7D40 cells for each time point in part A was determined with Image J. The ratio of the band
intensities before the addition of cycloheximide (time=0) was set as 1 and the error bars indicate the deviations between duplicates. (E) Cells of part
B, lines 1 to 4, were grown in glucose liquid media to OD600 nm=1 and induced with galactose liquid media for 8 h. Total RNA was isolated and GAL1
mRNA was determined relative to ACT1 mRNA by quantitative real-time PCR. The value determined for 22-SRB7 cells grown with glucose liquid media
was set as 1 and the error bars indicate the standard deviations between three replicates. (F) Whole-cell extracts of JD52 cells expressing the indicated
Srb7 derivatives in place of endogenous Srb7 and Nub-HA-Skp1 were incubated with glutathione beads, and precipitates were washed five times.
Inputs and precipitates were analyzed by Western blot with an anti-HA antibody (upper panel) and with an anti-GST antibody (lower panels).
doi:10.1371/journal.pbio.1001290.g005
Mediator Acts Upstream of Activator
PLoS Biology | www.plosbiology.org 8 March 2012 | Volume 10 | Issue 3 | e1001290replaced by a Srb7 mutant protein that failed to interact with
Skp1, suggesting that the protein-protein interaction between the
Mediator component Srb7 and the SCF component Skp1 is
required for the protein degradation of Gal80.
Snf1 Directs Galactose-Induced Gal80 Degradation
Mediator acts upstream of the activator Gal4 by controlling the
galactose-induced protein degradation of the inhibitor Gal80. But
how does Mediator know about the switch in carbon source? The
protein kinase Snf1 is required for the transcription of glucose-
repressed genes in S. cerevisiae, and the deletion of SNF1 resulted in
the failure to degrade Gal80 (Figure 6A, lanes 19 to 24; Figure 6B,
grey bars), to utilize galactose (Figure 6C), and to activate the
GAL1 gene under inducing conditions (Figure 6D). The activating
gamma subunit Snf4 is required for the kinase activity of the SNF1
complex and Gal80 was also stable in galactose-induced DSNF4
cells (Figure 6A, lanes 31 to 36; Figure 6B, grey bars), indicating
that the kinase activity of the SNF1 complex is required for the
degradation of Gal80. The additional gene deletion of GAL80 fully
suppressed the transcriptional defect of DSNF1 and DSNF4 cells
(Figure 6C, lines 3 and 4; Figure 6D), but no interaction was
observed between Snf1 and Gal80 in a pulldown assay (Figure
S10), indicating that Snf1 controls GAL1 expression mainly by
targeting Gal80 via Srb7 and SCF E3 ubiquitin ligases. The Split-
Ubiquitin assay did not reveal an interaction between Snf1 and
Srb7 (Figure S11, line 23), however Srb7 is a component of
Mediator and Snf1 interacted with the Mediator components
Med6 (Figure S11, line 6), Med10 (Figure S11, line 11), Srb6
(Med22; Figure S11, line 21), and Srb11 (CycC; Figure S11, line
27). The protein interaction between the kinase Snf1 and the
Mediator component Srb11 had been observed both in vivo and
in vitro previously [50,51]. Srb11 is a cyclin-like cofactor for the
protein kinase Srb10 (Cdk8), and the Mediator components Srb10
and Srb11 are both required for the full transcriptional activation
of the GAL1 gene [52]. Gal80 was stable in galactose-induced
DSRB10 and DSRB11 cells (Figure S12A, lanes 7 to 12 and 19 to
Figure 6. The protein kinase Snf1 is required for galactose-induced protein degradation of Gal80. (A) BY4742DW (lanes 1 to 12),
BY4742DWDSNF1 (lanes 13 to 24), and BY4741DWDSNF4 (lanes 25 to 36) cells expressing HA-tagged Gal80 under the control of the ACT1 promoter
were grown in glucose liquid media to OD600 nm=1 and induced with galactose liquid media for 1 h. Cycloheximide was added at time=0 and the
amount of Gal80 protein remaining in the cells after the indicated number of minutes was determined by Western blot with the help of an anti-HA
antibody (upper panels). The membranes were stripped and reprobed with an anti-CPY antibody (middle panels), followed by a second stripping and
staining with Coomassie Blue as loading controls (lower panels). (B) The ratio of the amount of HA-Gal80 protein to CPY protein in BY4742DW cells
(white bars), BY4742DWDSNF1 cells (black bars), and BY4741DWDSNF4 cells (grey bars) for each time point in part A was determined with Image J. The
ratio of the band intensities before the addition of cycloheximide (time=0) was set as 1 and the error bars indicate the deviations between
duplicates. (C) BY4742DW cells (lines 1 to 3) and BY4741DW cells (lines 4 to 6) of the indicated genotype were 10-fold serially diluted, dropped onto
the depicted plates, and incubated for 6 d at 28uC. The galactose plate contained 1 mg/l Antimycin A. (D) Cells of part C, lines 1 to 3, were grown in
glucose liquid media to OD600 nm=1 and induced with galactose liquid media for the indicated number of hours. Total RNA was isolated and GAL1
mRNA was determined relative to ACT1 mRNA by quantitative real-time PCR. The value determined for BY4742DW cells grown with glucose liquid
media was set as 1 and the error bars indicate the standard deviations between three replicates.
doi:10.1371/journal.pbio.1001290.g006
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to degrade Gal80 via the Mediator subunit Srb11. The additional
gene deletion of GAL80 suppressed the galactose utilization defect
of cells lacking Srb10 and Srb11 (Figure S12C, lines 3 and 5),
providing genetic evidence that galactose-stable Gal80 had caused
the gal
2 phenotype of DSRB10 and DSRB11 cells.
The SNF1 kinase is activated by the absence of glucose, but
transcriptional activation of the GAL genes requires additionally
the presence of galactose, as transcription of GAL1 is not activated
in cells grown with—for example—raffinose (Figure S13B).
Consistently, Gal80 was more stable in cells grown with raffinose
than in cells grown with galactose (Figure S14). The half-life of
Gal80 in BY4741DW cells was calculated to be approximately 3 h
when the cells were grown with glucose, 2 h when the cells were
grown with raffinose, 1 h when galactose-induced cells had been
pre-grown with glucose, and half an hour when the galactose-
induced cells had been pre-grown with raffinose. However, our
observations also indicate that active SNF1 kinase is necessary but
not sufficient for the galactose-stimulated protein degradation of
Gal80. An additional transducer that signals the presence of
galactose is apparently required. A possible candidate for such a
signal transducer is Gal3, as it is known to bind both galactose and
Gal80 [14]. Cells lacking Gal3 display a strong gal
2 phenotype
(Figure S15A, lines 3 and 4), which is suppressed by the additional
gene deletion of GAL80 (Figure S15A, lines 5 and 6), but the
degradation of Gal80 in galactose-induced cells remained
unchanged upon the deletion of GAL3 (Figure S15B, lanes 5 to
8; Figure 15C), indicating that Gal3 does not play a role in the
galactose-induced protein degradation of Gal80 and that galactose
must utilize another transducer to stimulate the protein degrada-
tion of Gal80.
Discussion
Mediator was isolated by its ability to respond to transcriptional
activators, and all studies published about Mediator have focused
on the role of Mediator past its recruitment to the promoter by the
activator [28]. Once recruited, Mediator is required to recruit the
General Transcription Factors and RNA Polymerase II and to
initiate transcription [29]. Mediator also affects post-initiation
steps by affecting transcription elongation and chromatin structure
[31]. We have shown here that Mediator additionally acts
upstream of the activator Gal4 by controlling the degradation of
the inhibitor Gal80. In cells grown with glucose, Gal80 binds to
the activation domain of Gal4 and prevents it from activating
transcription. Upon galactose induction, Mediator initiates the
degradation of Gal80 via its interaction with the SCF E3 ubiquitin
ligase component Skp1. Therefore, Mediator actually orchestrates
its own recruitment to the GAL1 promoter by regulating the
activity of Gal4 (Figure 7).
SCF
Mdm30 targets not only Gal80 but also Gal4 in galactose-
induced cells, leading to the mono-ubiquitination and subsequent
poly-ubiquitination and protein degradation of Gal4 [20]. In
galactose-induced cells lacking Mdm30, Gal4 is no longer
ubiquitinated and no longer degraded [20]. One could argue that
changes in the proteolytic stability of Gal4 or in its mono-
ubiquitination status might have been the cause for the gal
2
phenotypes that we have observed for the various H10UbD58A,
skp1, mdm30, srb7, and snf1 mutant strains described here.
Therefore, it is important to note that our claim that the
degradation of Gal80—and not the degradation of Gal4—is
required for the transcriptional activation of the GAL genes is not
just based on a simple correlation between the proteolytic stability
of Gal80 and the inability of the cell to activate transcription of the
GAL1 gene, but on functional suppression. The additional gene
deletion of GAL80 fully suppressed the transcriptional defects of
the H10UbD58A, skp1, mdm30, srb7, and snf1 mutant strains. This
means that in the absence of Gal80, Gal4 activated transcription
in all these mutant strains just fine, which demonstrates that any
effects that these strain mutations might have had on Gal4 were
not relevant for Gal4’s function as a transcriptional activator.
Therefore, while mono-ubiquitination of Gal4 was certainly
affected in the H10UbD58A strain (since endogenous wild-type
ubiquitin had been replaced with H10UbD58A), Gal4-
H10UbD58A fully activated transcription of the GAL1 gene in
the absence of Gal80, suggesting that H10UbD58A still protected
Gal4 from the UAS-stripping activity of the 19S proteasome [25].
Furthermore, Gal4 fully activated transcription in cells lacking
both Mdm30 and Gal80, which argues that Gal4 does not have to
be degraded to become transcriptionally active. In addition, we
have generated a galactose-stable Gal80 derivative that inhibited
galactose induction in otherwise wild-type cells, which means that
we have presented evidence for our claim that galactose induction
requires Gal80 degradation that did not rely on a mutant strain
background.
The deletion of the three F-box protein-coding genes MDM30,
DAS1, and UFO1 completely abolished galactose induction of
GAL1 mRNA (Figure 3D and [37]). Das1 and Ufo1 (but not
Mdm30) also target the repressor Mig2 for galactose-induced
protein degradation [37]. However, the additional gene deletion of
MIG2 did not increase galactose induction of GAL1 mRNA in the
DUFO1 strain and had only a very small effect on the galactose
induction of the GAL1 mRNA in the DDAS1 strain [37].
Therefore, an additional target for Das1 and Ufo1 had been
proposed, and we have now shown here that Gal80 is this
functionally relevant target, as Gal80—like Mig2 [37]—became
stable in galactose-induced cells lacking Das1 and Ufo1 (Figure
S7A and S7B), and the additional gene deletion of GAL80
suppressed the gal
2 phenotype of both the DDAS1 and the DUFO1
strains (Figure S7C). We are proposing that a critical concentra-
tion of the three F-box proteins Mdm30, Das1, and Ufo1 is
required for the galactose-stimulated protein degradation of
Gal80. If any one of these three F-box proteins is missing, the
concentration of the remaining two F-box proteins is insufficient
for targeting of Gal80; Gal80 is not degraded and excess Gal80
prevents Gal4 from activating the GAL genes under inducing
conditions. In support of this model (Figure 7), we were able to
show that the gal
2 phenotype of DDAS1 cells was suppressed by
the over-expression of Ufo1 and Mdm30 (Figure S7E).
Gal3 sequesters Gal80 in the cytoplasm upon galactose
induction [14]. The gene deletion of GAL3 had caused a gal
2
phenotype that was suppressed by the additional gene deletion of
GAL80, but the protein degradation of Gal80 was still stimulated in
galactose-induced cells lacking Gal3 (Figure S15), indicating that
instable Gal80 was not sufficient to allow Gal4 to activate
transcription in the absence of Gal3. On the other hand,
sequestration of Gal80 into the cytoplasm by endogenous levels
of Gal3 was not sufficient to allow Gal4 to activate transcription in
the presence of stable Gal80. Apparently, sequestration of Gal80
into the cytoplasm by Gal3 and ubiquitin-mediated protein
degradation of Gal80 are both required for the galactose induction
of the GAL genes.
Contrary to a previous report [20], we found that the deletion of
the gene encoding the F-box protein Mdm30 abolished galactose
induction of the GAL1 mRNA. We have grown the cells in glucose
liquid media prior to the switch to galactose liquid media—which
is consistent with the switch in carbon sources conducted for the
plate assay—while Muratani et al. grew the cells in raffinose liquid
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determine if this difference in protocols was the cause for the
difference in results, we performed the galactose induction with
cells that had been pre-grown in raffinose, and we found that in
this case, galactose-induced protein degradation of Gal80 and
galactose induction of GAL1 mRNA relative to ACT1 mRNA were
restored in the DMDM30 strain (Figures S13B and S14). One
other remarkable difference between the two growth protocols is
the speed of induction. Galactose induction of GAL1 mRNA
relative to ACT1 mRNA takes 4 h if the cells are pre-grown with
glucose and only 1 h if the cells are pre-grown with raffinose
(Figure S16). Consistently, cycloheximide chase assays demon-
Figure 7. How Mediator orchestrates its own recruitment to the GAL1 promoter. (A) The protein kinase SNF1 senses the absence of glucose
and phosphorylates Mig2. Phosphorylated Mig2 is ubiquitinated by the E3 ubiquitin ligases SCF
Das1/Ufo1 [37]. SNF1 also signals Mediator the absence
of glucose via the Snf1-Srb11 interaction. Mediator transduces the signal to the E3 ubiquitin ligases SCF
Mdm30/Ufo1/Das1 via the Srb7-Skp1 interaction.
SCF
Mdm30/Ufo1/Das1 ubiquitinate Gal80 via the interaction of Gal80 with the F-box proteins Mdm30, Ufo1, and Das1. (B) Poly-ubiquitinated Gal80 and
Mig2 are degraded by the 26S proteasome. (C) Gal4 recruits chromatin-remodeling and chromatin-modifying complexes as well as the Holoenzyme
of Transcription (consisting of RNA Polymerase II, the General Transcription Factors, and Mediator) to the GAL1 promoter genes via the Gal4-Gal11
interaction [43].
doi:10.1371/journal.pbio.1001290.g007
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cells when the cells had been pre-grown with raffinose instead of
with glucose (compare Figures 3B and S14B). The half-life of
Gal80 in galactose-induced BY4741DW cells was approximately
1 h when the cells had been pre-grown with glucose and only half
an hour when the cells had been pre-grown with raffinose. The
correlation of the kinetics of galactose-induced Gal80 destruction
and GAL1 mRNA production suggests that the degradation of
Gal80 is the rate-limiting step for the galactose induction of the
GAL1 gene.
Materials and Methods
Strains and Plasmids
The S. cerevisiae strain SUB288 [53] has all chromosomal
ubiquitin genes deleted and allows for the expression of plasmid-
born ubiquitin derivatives in place of endogenous ubiquitin (see
Table S1 for the genotypes of the strains and Table S2 for the
sequences of PCR primers). However, the strain fails to grow on
galactose plates containing the respiration inhibitor Antimycin A
(AA). Transformation of the strain with single-copy vectors
expressing Gal3 from its own promoter allowed the strain to grow
on galactose AA plates and sequencing of the chromosomal GAL3
gene demonstrated that SUB288 carries a frame shift in the third
codon of GAL3. The TRP1 and LEU2 genes were deleted and the
defective gal3 gene was repaired by homologous recombination
with a wild-type GAL3 PCR fragment followed by selection on a
galactose AA plate or with YIplac204-GAL3, a derivative of the
TRP1-marked integrative vector YIplac204 [54] containing the
GAL3 gene, resulting in SUB288GAL3DWL+316-Ub and SUB288-
GAL3DL+316-Ub, respectively. DNA sequencing of PCR frag-
ments derived from genomic DNA was used to confirm that the
GAL3 gene had been repaired. The ubiquitin point mutants were
generated by two-step PCR with degenerate primers and cloned
into the LYS2-marked single-copy vector RS317 [55] containing
the ACT1 promoter-terminator cassette and into RS317 expressing
10 histidines from the ACT1 promoter. The 317-Ub and 317-H10-
Ub plasmids were transformed into SUB288GAL3DWL+316-Ub
and 316-Ub was shuffled out on FOA plates. All ubiquitin mutant
strains were confirmed by DNA sequencing. The GAL80 gene of
SUB288GAL3DWL+317-Ub was knocked out with a derivative of
NKY51 [56], which carried the hisG-URA3-hisG cassette in the BglII
site at nucleotide 612 of GAL80. 317-Ub was replaced by 316-Ub
via plasmid loss, and plasmid shuffle was used to generate the 317-
H10-Ub and 317-H10-UbD58A strains carrying hisG integrated
into GAL80. The essential SRB7 gene of JD52 and JD52DGAL80
was knocked out with a PCR fragment containing the HIS3 gene
flanked by 50 bp of SRB7 promoter and terminator in the
presence of 33-SRB7, a derivative of the URA3-marked single-copy
vector YCplac33 [54] that expressed Srb7 from its own promoter.
GST-Srb7 and GST-Srb7D40 were expressed from the TRP1-
marked multi-copy vector YG1m under the control of the ADH1
promoter. BY4741DW and BY4742DW and their gene deletion
derivatives were obtained from the respective EUROSCARF
strains by inserting hisG into the TRP1 gene with the help of
NKY1009 [56]. YEp13-GAL3 was isolated from a LEU2-marked
multi-copy YEp13-based genomic DNA library [37] as a multi-
copy suppressor of the gal
2 phenotype of the H10UbD58A strain.
YEp13-GAL3 contains a 2,643 bp genomic DNA fragment with
the entire GAL3 gene, including 842 bp of promoter and 238 bp of
terminator DNA. 112-GAL3 is a derivative of the TRP1-marked
multi-copy vector YEplac112 [54] containing the genomic GAL3
fragment. 314-Gal3 is a derivative of the TRP1-marked single-copy
vector RS314 [55], expressing Gal3 from the ACT1 promoter. 315-
Gal3 is a derivative of the LEU2-marked single-copy vector RS315
[55], expressing Gal3 from the ACT1 promoter. 316-HA-Gal80 is a
derivative of RS316, expressing Gal80 from the ACT1 promoter.
The N-terminal deletion derivatives of Gal80 were cloned into the
same vector. 423-HA3-Mdm30, 423-HA3-Das1, and 423-HA3-Ufo1
are derivatives of the HIS3-marked multi-copy vector RS423 [55],
expressing Mdm30, Das1, and Ufo1 tagged with three HA
epitopes from the ACT1 promoter. 424-GST and 424-GST-Gal80
are derivatives of the TRP1-marked multi-copy vector RS424 [55],
expressing GST and GST-Gal80 from the ACT1 promoter.
YIplac128-Snf1c-HA3H10 is a derivative of the LEU2-marked
integrative vector YIplac128 [54], containing a C-terminal BglII-
SalI fragment of SNF1 lacking the stop codon, and YIplac128-
Skp1c-HA3H10 is a derivative of YIplac128 containing a C-terminal
EcoRI-SalI fragment of SKP1 lacking the stop codon. Snf1-HA3H10
was expressed from the SNF1 promoter following digestion with
MluI and integration into the SNF1 locus, while Skp1-HA3H10 was
expressed from the SKP1 promoter following digestion with AvaI
and integration into the SKP1 locus.
Split-Ubiquitin Screen
A Clontech library derived from human B-cell cDNAs was
partially digested with Sau3A and cloned into the BglII site of
PADNX-Nub-IBC [57] in all three reading frames, resulting in
60,000 independent DH5a transformants. hSrb7 was cloned into
Pcup1-Cub-RUra314 [57] and transformed together with the Nub
library into JD52 [58], resulting in 160,000 transformants, which
were plated onto FOA plates containing 10 mM CuSO4. The Nub
plasmids from the 10 arising colonies were isolated and
transformed back into JD52 containing hSrb7-Cub-Ura314. Only
one was plasmid-linked, and it contained the entire hSkp1 open
reading frame fused to Nub-HA.
mRNA Quantification
HeLa cells were grown to 80% confluency and transfected with
2 mg of pSuper (OligoEngine) construct and 5 ml of lipofectamin in
serum-free DMEM for 5 h before being transferred into regular
DMEM. The three constructs used were an empty vector as a
negative control, siRNA specific for hSKP1, and siRNA specific for
hSRB7. 48 h after transfection, one set of cells was heat-shocked at
45uC for 15 min and allowed to recover for 1 h in a 37uC
incubator. A non-heat-shock sample was also incubated at 37uC
for an identical length of time. These cells were then harvested by
trypsinization and their mRNA was extracted using a Qiagen
RNA Easy Kit. 300 nM of mRNA was utilized for reverse
transcription primed by random hexamers, and the cDNA was
quantified using Sybr-Green in an ABI Prism. Primers for
HSP70B’ mRNA were 59-ccccatcattgaggaggttg-39 and 59-gaagca-
gaagaggatgaacc-39. Primers for hSKP1 mRNA were 59-gcaaaga-
gaaccagtggtgtga-39 and 59-aggtttgggatctgtgctcaa-39. Primers for
hSRB7 mRNA were 59-aatgtggtcctcctgcctctt-39 and 59-ccagaag-
catgtctcctcgata-39. Primers for GAPDH mRNA were 59-
ctctctgctcctcctgttcgac-39 and 59-tgagcgatgtggctcggct-39.
S. cerevisiae cells were cultured in synthetic complete 2% (w/v)
glucose medium at 28uC. At OD600 nm=1, the cells were collected
by centrifugation. Galactose induction was performed by resus-
pending the cells in 2% galactose medium and incubation for the
indicated amount of time. Total RNA was isolated using the
RNAeasy Mini Kit (Qiagen) according to the manufacturer’s
protocol. cDNA was generated by reverse transcription PCR using
Taqman MicroRNA Reverse Transcription Kit (Roche Applied
Biosystems). Quantitative real-time PCR was performed using
SYBR Green PCR Master Mix (Applied Biosystems). Primers used
for ACT1 mRNA were 59-gaccaaactacttacaactcca-39 and 59-
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acttgcaccggaaaggtttg-39 and 59-ttggtacatcaccctcacagaaga-39. All
mRNA quantifications were performed three times, and the error
bars represent the standard deviations.
Coimmunoprecipitation
HeLa cells were grown to 80% confluency before they were
transfected with 2 mgo fpCMV-myc-hSKP1 or pCMV-myc vector and
5 ml of lipofectamin in serum-free DMEM for 5 h before being
transferred into regular DMEM. The cells were harvested 48 h
after transfection by trypsinization and lysed in 16PBS by freeze-
thaw. The cell lysate was subsequently agitated on a rotor with
2 ml of anti-myc affixed agarose beads (Sigma) in 500 ml of ice cold
16PBS overnight. The beads were washed four times with 1 ml
PBS prior to heat elution at 95uC for 15 min. Proteins were
separated on a 12% gel, transferred to a nitrocellulose membrane,
which was probed with anti-Med6 rabbit polyclonal antibody
(Abcam).
HeLa cells were grown to 80% confluency before they were
harvested by trypsinization and lysed in 16PBS by freeze-thaw.
The cell lysate was diluted 1:5 with RIPA buffer (50 mM Tris-HCl
ph 8, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.5% Sodium
deoxycholate, 0.1% SDS) and incubated with 10 ml of rProtein G
Sepharose (GE Healthcare) as well as 5 ml of anti-Med6 rabbit
polyclonal antibody (Abcam) or anti-Cul1 mouse monoclonal
antibody (Abcam) for 3 h. The sepharose was washed four times
with 1 ml PBS and heat eluted at 95uC for 15 min. Proteins were
separated on a 12% gel and transferred to a nitrocellulose
membrane, which was probed with the reciprocal antibody (anti-
Cul1 mouse monoclonal antibody (Abcam) or anti-Med6 rabbit
polyclonal antibody (Abcam), respectively).
GST Pulldown Assays
GST pulldown assays were performed using whole cell S.
cerevisiae extracts prepared by bead beating in yeast lysis buffer
(100 mM Tris pH 7.5, 50 mM KCl, 1 mM EDTA, 0.1% NP40)
and whole cell E. coli extracts prepared by freeze-thaw in PBS
(Phosphate-Buffered Saline). 500 ml of whole cell extract was
added to equilibrated glutathione beads (Amersham Biosciences)
containing 2 mM PMSF and 1 mM DTT. The reaction mixture
was incubated at 4uC for 1 h. The sample was centrifuged at
3,000 rpm and the supernatant was removed. The glutathione
beads were washed five times before Western Blot analysis.
Ni Pulldown Assays
S. cerevisiae cells were grown in 50 ml synthetic complete 2%
glucose medium to OD600 nm=1 and harvested by centrifugation.
The cell pellets were suspended in 1 ml yeast breaking buffer
(Triton X-100, 10% SDS, 5 M NaCl, 1 M Tris-Hcl pH 8, 0.5 M
EDTA; Figure 5D) or yeast lysis buffer (Figure S6), pipetted into a
screw-cap microcentrifuge tube containing acid-washed glass
beads (Sigma-Aldrich, USA), and 2 mM PMSF was added. The
tubes were then subjected to homogenization with a bead beater
for 1 min and then rested on ice for 3 min. This process was
repeated for three times. The samples were then centrifuged for
15 min at 13,000 rpm, and the supernatants were incubated with
10 ml of equilibrated nickel beads for 1 h at 4uC. After incubation,
the samples were centrifuged at 3,000 rpm for 2 min. The nickel
beads were washed with 1 ml yeast breaking/lysis buffer
containing 20 mM imidazole. This washing process was repeated
five times. The bound protein was eluted from the nickel beads
using 100 ml of yeast breaking/lysis buffer with 500 mM imidazole
for 30 min. This process was repeated two times. The supernatant
was collected and stored at 280uC.
Cycloheximide Chase Assays
S. cerevisiae cells were grown in liquid drop out media containing
2% glucose or raffinose to OD600 nm=1. Half of the cultures were
induced in liquid media containing 2% galactose for 1 h before the
addition of 200 mg/l cycloheximide (Sigma). Aliquots were taken
at the indicated time points, and cellular proteins were analyzed by
Western Blot with primary antibodies against hemagglutinin (HA;
Roche) and carboxypeptidase Y (CPY; Molecular Probes),
followed by staining with a horseradish peroxidase-coupled
secondary anti-mouse IgG antibody and by Coomassie Brilliant
Blue (Sigma) staining. The intensities of the bands were quantified
with Image J (rsb.info.nih.gov/ij/index.html). The ratio of the
band intensities before the addition of cycloheximide (time=0)
was set as 1, and the error bars represent the deviations between
duplicates. Representative Western blots are shown. No significant
differences were observed when the HA-Gal80 bands were
normalized to CPY or to Coomassie staining. The half-life of
Gal80 was calculated using trendline (excel).
Supporting Information
Figure S1 Identification of galactose utilization-defective Ub
mutants. Ten-fold serial dilutions of SUB288GAL3DWL cells
expressing the indicated ubiquitin derivatives in place of
endogenous ubiquitin were titrated onto the depicted plates and
incubated at 28uC for 6 d. The ubiquitin derivatives were
expressed from the LYS2-marked single-copy vector RS317 under
the control of the ACT1 promoter. The galactose plates contained
1 mg/l of the respiration inhibitor Antimycin A (AA).
(TIF)
Figure S2 Summary of the results of the alanine scans of
ubiquitin and histidine-tagged ubiquitin. All residues of ubiquitin
other than alanine and glycine were replaced by alanine one by
one, and cells expressing the indicated ubiquitin derivative in place
of endogenous ubiquitin were tested for viability by growth on
plates containing FOA and for the gal
2 phenotype by growth on
galactose plates containing the respiration inhibitor Antimycin A.
2 indicates lack of growth and + indicates growth.
(TIF)
Figure S3 The over-expression of Gal3 dosage compensates the
gal
2 phenotype of all ubiquitin mutants. Ten-fold serial dilutions of
SUB288GAL3DWL cells expressing the indicated ubiquitin deriv-
ative in place of endogenous ubiquitin that contained RS315 (odd
lanes) or that over-expressed Gal3 from RS315 under the control
of the ACT1 promoter (even lanes) were 10-fold serially diluted,
titrated onto the indicated plates, and incubated for 6 d at 28uC.
The Galactose+AA plate contained 1 mg/l Antimycin A.
(TIF)
Figure S4 The additional gene deletion of GAL80 suppresses the
gal
2 phenotype of all gal
2 ubiquitin mutants. Ten-fold serial
dilutions of SUB288GAL3DWL cells expressing the indicated
ubiquitin derivative in place of endogenous ubiquitin that
contained the GAL80 gene (odd lanes) or that lacked the
GAL80 gene (even lanes) were 10-fold serially diluted, titrated
onto the indicated plates, and incubated for 3 d at 28uC. The
Galactose+AA plate contained 1 mg/l Antimycin A.
(TIF)
Figure S5 HA-Gal80 is stable in the gal
2 H10Ub mutant strains.
Left panels: SUB288GAL3DL cells expressing the indicated H10Ub
derivatives in place of endogenous ubiquitin were transformed
with the single-copy vector RS316 expressing HA-Gal80 under the
control of the ACT1 promoter. Cells were grown in glucose liquid
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for 1 h. Cycloheximide was added at time=0 and the amount of
Gal80 protein remaining in the cells after the indicated number of
hours was determined by Western blot with the help of an anti-HA
antibody (upper panels). The membranes were stripped and
reprobed with an anti-CPY antibody (middle panels), followed by
a second stripping and staining with Coomassie Blue as loading
controls (lower panels). Right panels: The ratio of the amount of
HA-Gal80 protein to the loading controls for each time point was
determined with Image J. The ratio of the band intensities before
the addition of cycloheximide (time=0) was set as 1 and the error
bars indicate the deviations between duplicates.
(TIF)
Figure S6 GST-Gal80, but not GST, co-precipitates Skp1-HA3-
H10. Endogenous Skp1 of BY4741DW cells was tagged with three
HA epitopes and 10 histidines. GST (lanes 1, 2, 5, 6) and GST-
Gal80 (lanes 3, 4, 7, 8) were expressed in these cells under the
control of the ACT1 promoter. Cells were grown with glucose
liquid media to OD600 nm=1 (odd lanes) and induced in galactose
liquid media for 1 h (even lanes). GST and GST-Gal80 were
pulled down from cell extracts with the help of glutathione beads,
and Inputs (lanes 1 to 4) and GST Pulldowns (lanes 5 to 8) were
analyzed by Western blots with the help of an anti-HA antibody
(upper panel) and an anti-GST-antibody (middle panel). The
membrane was stripped and stained with Coomassie in order to
compare the amount of protein loaded for Input and GST
Pulldown (bottom panel).
(TIF)
Figure S7 Das1 and Ufo1 target Gal80. (A) HA-tagged Gal80
was expressed in BY4741DW (lanes 1 to 8), BY4741DWDDAS1
(lanes 9 to 16), and BY4741DWDUFO1 (lanes 17 to 24) cells from
the single-copy vector RS316 under the control of the ACT1
promoter. Cells were grown in glucose liquid media to
OD600 nm=1 and induced with galactose liquid media for 1 h.
Cycloheximide was added at time=0 and the amount of Gal80
protein remaining in the cells after the indicated number of hours
was determined by Western blot with the help of an anti-HA
antibody (upper panels). The membranes were stripped and
stained with Coomassie Blue as loading controls (lower panels). (B)
The ratio of the amount of HA-Gal80 protein to total protein
(Coomassie) in BY4741DW cells (white bars), BY4741DWDDAS1
cells (black bars), and BY4741DWDUFO1 cells (grey bars) for each
time point in part A was determined with Image J. The ratio of the
band intensities before the addition of cycloheximide (time=0)
was set as 1 and the error bars indicate the deviations between
replicates. (C) BY4741DW cells of the indicated genotype were 10-
fold serially diluted, titrated onto the indicated plates, and
incubated at 28uC for 3 d on the glucose plate and for 6 d on
the galactose+AA (=0.1 mg/l Antimycin A) plate. (D) HA3-
tagged Das1 and GST (lanes 1, 2, 6, 7) or GST-Gal80 (lanes 3, 4,
8, 9) were expressed in BY4741DW cells under the control of the
ACT1 promoter from the multi-copy vectors RS423 and RS424,
respectively. Cells were grown with glucose liquid media to
OD600 nm=1 (odd lanes) and induced in galactose liquid media for
1 h (even lanes). GST and GST-Gal80 were pulled down from cell
extracts with the help of glutathione beads, and Inputs and GST
Pulldowns were analyzed by Western blots with the help of an
anti-HA antibody (upper panel) and an anti-GST-antibody (lower
panel). The size marker (M) was loaded into lane 5 and the dots
indicate the positions of the marker bands of 150 kD, 100 kD,
75 kD (upper panel) and 100 kD, 75 kD, 50 kD, 37 kD (two dots),
and 25 kD (lower panel). (E) HA3-tagged Ufo1 and GST (lanes 1,
2, 6, 7) or GST-Gal80 (lanes 3, 4, 8, 9) were expressed in
BY4741DW cells under the control of the ACT1 promoter from the
multi-copy vectors RS423 and RS424, respectively. Cells were
grown with glucose liquid media to OD600 nm=1 (odd lanes) and
induced in galactose liquid media for 1 h (even lanes). GST and
GST-Gal80 were pulled down from cell extracts with the help of
glutathione beads, and Inputs and GST Pulldowns were analyzed
by Western blots with the help of an anti-HA antibody (upper
panel) and an anti-GST-antibody (lower panel). The size marker
(M) was loaded into lane 5. See part D for the marker sizes. (F)
BY4741DW cells of the indicated genotype were 10-fold serially
diluted, titrated onto the indicated plates, and incubated at 28uC
for 6 d. Cells in line 3 over-expressed Ufo1 and cells in line 4 over-
expressed Mdm30 from the ACT1 promoter. The galactose plate
contained 1 mg/l Antimycin A (AA).
(TIF)
Figure S8 hSrb7 interacts with hSkp1 in vitro and in vivo. (A)
The Split-Ubiquitin assay. Two proteins of interest X and Y are
fused to the N-terminal half of ubiquitin and to the C-terminal half
of ubiquitin extended by the RUra3 reporter, Nub and Cub-
RUra3, respectively. The protein interaction between X and Y
brings the two halves of ubiquitin into close proximity, which
causes Ubiquitin-specific proteases (Ubps) to cleave off RUra3,
which is subsequently degraded by the enzymes of the N-end rule.
The protein interaction between X and Y can therefore be
selected for on plates containing 5-fluoro orotic acid (FOA), as
Ura3 (orotidine-59-phosphate decarboxylase) converts FOA into
toxic fluoro uracil. (B) JD52 cells expressing the indicated fusions
were 10-fold serial diluted, titrated onto the depicted plates, and
incubated for 3 d. Protein interaction is revealed by growth on the
FOA plate and lack of growth on the uracil-depleted plate. (C)
GST fusions purified from E. coli extracts with glutathione beads
were incubated with E. coli extract containing H6-HA-hSrb7 (lanes
2, 3) and with S. cerevisiae extract containing Nub-HA-hSkp1 (lanes
5, 6). Precipitates were washed five times and analyzed by Western
blot with an anti-HA antibody. (D) The human Split-Ubiquitin
system. Two proteins of interest X and Y are fused to the N-
terminal half of ubiquitin and to the C-terminal half of ubiquitin
extended by the RGpt2 reporter, Nub and Cub-RGpt2,
respectively. The protein interaction between X and Y brings
the two halves of ubiquitin into close proximity, which causes
Ubiquitin-specific proteases (Ubps) to cleave off RGpt2, which is
subsequently degraded by the enzymes of the N-end rule. The
protein interaction between X and Y causes sensitivity to
hypoxanthine/aminopterin/thymine (HAT) media and resistance
to 6-thioguanine (6TG). (E) Human HT1080HPRT
2 fibroblast
cells stably expressing hSrb7-Cub-RGpt2 and Nub (left panels) or
hSrb7-Cub-RGpt2 and Nub-hSkp1 (right panels) were placed into
control media (top panels), into HAT media (middle panels), or
into media containing 6TG (bottom panels). In HAT media, the
cells require functional Gpt2 (hypoxanthine-guanine phosphor-
ibosyltransferase) enzyme, whereas 6TG media counter-selects
against Gpt2 function. Growth in 6TG media and lack of growth
in HAT media indicates that hSrb7 interacts with hSkp1 inside the
tissue culture cells.
(TIF)
Figure S9 Mediator interacts with SCF E3 ubiquitin ligases. (A)
Whole cell extracts of HeLa cells expressing myc-tagged hSkp1
(lanes 1 to 3) were incubated with anti-myc beads (lane 3). Whole
cell extracts from untransfected HeLa cells (lanes 4 to 10) were
incubated with an anti-hCul1 antibody (lanes 5 and 8) and with an
anti-hMed6 antibody (lane 10). Antibodies were precipitated with
Protein G-coupled beads. Inputs and precipitates were analyzed
by Western blot with an anti-hMed6 antibody (lanes 1 to 5) and
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transfected with empty vector (Control) or with pSuper containing
siRNA against hSRB7 and hSKP1. Real-time PCR was used to
quantify the amount of hSRB7 mRNA and hSKP1 mRNA relative
to GAPDH mRNA. The value obtained for cells transformed with
the empty vector was set as 1 and the error bars indicate the
standard deviations between three replicates. (C) HeLa cells
transfected with pSuper (control) or with pSuper containing
siRNA against hSRB7 and hSKP1 were grown at 37uC (No Heat-
Shock) or placed at 42uC for 15 min 1 h prior to RNA isolation
(Heat-Shock). Real-time PCR was used to quantify the amount of
HSP70B mRNA relative to GAPDH mRNA. The value obtained
for non-heat-shocked cells transformed with pSuper was set as 1
and the error bars indicate the standard deviations between three
replicates.
(TIF)
Figure S10 Snf1 does not interact with Gal80. (A) HA-Gal80 is
functional. BY4742DW cells of the indicated genotype were 10-
fold serially diluted, dropped onto the depicted plates, and
incubated at 28uC for 6 d. The cells in the top three lines
contained RS317 and the cells in the bottom line expressed HA-
Gal80 from RS317 under the control of the ACT1 promoter. The
Galactose+AA plate contained 0.1 mg/l Antimycin A. (B) Snf1-
HA3-H10 is functional. BY4742DW and BY4742DWDSNF1 cells
transformed with the LEU2-marked single-copy vector YCplac111
as well as BY4742DW cells expressing Snf1 chromosomally tagged
with three HA epitopes and 10 histidines were 10-fold serial
diluted and titrated onto the indicated plates and incubated at
28uC for 6 d. (C) BY4742DW cells transformed with YCplac111
(lanes 1, 5) and BY4742DW cells expressing Snf1-HA3-H10 from
the endogenous SNF1 locus (lanes 2, 3, 4, 6, 7, 8) were transformed
with RS317 (lanes 1, 2, 5, 6) or with RS317 expressing HA-Gal80
from the ACT1 promoter (lanes 3, 4, 7, 8). Cells were grown in
glucose liquid media to OD600 nm=1 (lanes 1, 2, 3, 6, 7) and
induced in galactose liquid media for 1 h (lanes 4, 8). Snf1-HA3-
H10 was pulled down from cell extracts with Ni-beads and Inputs
(lanes 1 to 4) and Ni-pulldowns (lanes 5 to 8) were analyzed by
Western blot with the help of an HA antibody (upper panel). The
membrane was stripped and stained with Coomassie as a loading
control (lower panel).
(TIF)
Figure S11 Snf1 interacts with Med6, Med10, Srb6, and Srb11.
JD52 cells expressing Snf1-Cub-RUra3 from the SNF1 locus in
place of endogenous Snf1 were transformed with the indicated
Nub fusions. Ten-fold serial dilutions of cells were titrated onto the
depicted plates and incubated at 28uC for 3 d (Glucose,
Glucose2Uracil, Galactose2Uracil) or 6 d (Glucose+FOA).
Protein-protein interaction between Snf1 and the Mediator
subunits is indicated by growth on the FOA plate and lack of
growth on the uracil-depleted plate. Functionality of the Snf1-
Cub-RUra3 fusion is indicated by the ability of the strain to utilize
galactose.
(TIF)
Figure S12 The Mediator subunits Srb10 and Srb11 are
required for the galactose-induced protein degradation of Gal80.
(A) BY4742DSRB10 (lanes 1 to 12) and BY4742DSRB11 (lanes 13
to 24) cells expressing HA-tagged Gal80 from RS317 under the
control of the ACT1 promoter were grown in glucose liquid media
to OD600 nm=1 (lanes 1 to 6 and 13 to 18) and induced with
galactose liquid media for 1 h (lanes 7 to 12 and 19 to 24).
Cycloheximide was added at time=0 and the amount of Gal80
protein remaining in the cells after the indicated number of
minutes was determined by Western blot with the help of an anti-
HA antibody (upper panels). The membranes were stripped and
reprobed with an anti-CPY antibody (middle panels), followed by
a second stripping and staining with Coomassie Blue as loading
controls (lower panels). (B) The ratio of the amount of HA-Gal80
protein to CPY protein in BY4742DW cells (white bars),
BY4742DSRB10 cells (black bars), and BY4742DSRB11 cells (grey
bars) for each time point in part A was determined with Image J.
The ratio of the band intensities before the addition of
cycloheximide (time=0) was set as 1 and the error bars indicate
the deviations between duplicates. The Western blots for the
BY4742DW wild-type control are presented in Figures 4C (lanes
1–12) and 6A (lanes 1–12). (C) Ten-fold serial dilutions of the
indicated strains were titrated onto the depicted plates and
incubated at 28uC for 3 d. The galactose plates contained 1 mg/l
of the respiration inhibitor Antimycin A.
(TIF)
Figure S13 Galactose induction of GAL1 mRNA is restored in
the DMDM30 strain, if the cells are pre-grown with raffinose
instead of with glucose. (A) BY4741DW wild-type and DMDM30
cells were grown in glucose liquid media to OD600 nm=1 (Glu)
and induced with galactose liquid media for 8 h (Gal 8 h). Total
RNA was isolated and GAL1 mRNA was determined relative to
ACT1 mRNA by quantitative real-time PCR. The value
determined for BY4741DW wild-type cells grown with glucose
liquid media was set as 1 and the error bars indicate the standard
deviations between three replicates. (B) BY4741DW wild-type and
DMDM30 cells were grown in raffinose liquid media to
OD600 nm=1 (Raf) and induced with galactose liquid media for
1 h (Gal 1 h). Total RNA was isolated and GAL1 mRNA was
determined relative to ACT1 mRNA by quantitative real-time
PCR. The value determined for BY4741DW wild-type cells grown
with raffinose liquid media was set as 1 and the error bars indicate
the standard deviations between three replicates.
(TIF)
Figure S14 Protein degradation of Gal80 is restored in the
DMDM30 strain, if the cells are pre-grown with raffinose instead of
with glucose. (A) HA-tagged Gal80 was expressed in BY4741DW
and BY4741DWDMDM30 cells from the single-copy vector RS316
under the control of the ACT1 promoter. Cells were grown in
raffinose liquid media (lanes 1 to 4 and 9 to 12) to OD600 nm=1
and induced with galactose liquid media for 1 h (lanes 5 to 8 and
13 to 16). Cycloheximide was added at time=0 and the amount of
Gal80 protein remaining in the cells after the indicated number of
hours was determined by Western blot with the help of an anti-HA
antibody (upper panels). The membranes were stripped and
reprobed with an anti-CPY antibody (middle panels), followed by
a second stripping and staining with Coomassie Blue as loading
controls (lower panels). (B) The ratio of the amount of HA-Gal80
protein to CPY protein in BY4741DW cells (white bars) and
BY4741DWDMDM30 cells (black bars) for each time point in part
A was determined with Image J. The ratio of the band intensities
before the addition of cycloheximide (time=0) was set as 1 and the
error bars indicate the deviations between duplicates.
(TIF)
Figure S15 Gal3 is not required for the galactose-stimulated
protein degradation of Gal80. (A) BY4741DW cells of the indicated
genotype were 10-fold serially diluted, dropped onto the depicted
plates, and incubated at 28uC for 3 d. The titrations were
performed in duplicates. The Galactose+AA plate contained
1 mg/l Antimycin A. (B) HA-tagged Gal80 was expressed in
BY4741DWDGAL3 cells from the single-copy vector RS316 under
the control of the ACT1 promoter. Cells were grown in glucose
liquid media (lanes 1 to 4) to OD600 nm=1 and induced with
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added at time=0 and the amount of Gal80 protein remaining in
the cells after the indicated number of hours was determined by
Western blot with the help of an anti-HA antibody (upper panel).
The membranes were stripped and reprobed with an anti-CPY
antibody (middle panel), followed by a second stripping and
staining with Coomassie Blue as loading control (lower panel). (C)
The ratio of the amount of HA-Gal80 protein to CPY protein for
each time point in part B was determined with Image J. The ratio
of the band intensities before the addition of cycloheximide
(time=0) was set as 1 and the error bars indicate the deviations
between duplicates.
(TIF)
Figure S16 The degradation of Gal80 as the limiting factor for
the activation of the GAL1 gene. (A) BY4741DW cells were grown
in glucose liquid media to OD600 nm=1 (0 h) and induced with
galactose liquid media for the indicated number of hours. Total
RNA was isolated and GAL1 mRNA was determined relative to
ACT1 mRNA by quantitative real-time PCR. The value
determined for BY4741DW cells grown with glucose liquid media
was set as 1 and the error bars indicate the standard deviations
between three replicates. (B) BY4741DW cells were grown in
raffinose liquid media to OD600 nm=1 (0 min) and induced with
galactose liquid media for the indicated number of minutes. Total
RNA was isolated and GAL1 mRNA was determined relative to
ACT1 mRNA by quantitative real-time PCR. The value
determined for BY4741DW cells grown with raffinose liquid
media was set as 1 and the error bars indicate the standard
deviations between three replicates.
(TIF)
Table S1 Genotypes and sources of strains used in this study.
(DOC)
Table S2 Names of plasmids constructed for this study and
DNA sequences of PCR primers used to generate these plasmids.
(DOC)
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